or Try an Advanced Search...

    Technical Analysis for CUE - Cue Biopharma, Inc.

    Grade Last Price % Change Price Change
    F 1.02 -17.74% -0.22
    CUE closed down 17.74 percent on Monday, July 1, 2024, on 3.93 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CUE trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Expansion Breakdown Bearish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Wide Range Bar Range Expansion 0.00%
    New 52 Week Low Weakness 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Older End-of-Day Signals for CUE ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 10 hours ago
    Up 2% about 10 hours ago
    Up 1% about 10 hours ago
    60 Minute Opening Range Breakdown 3 days ago
    Down 5% 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CUE Chart by TradingView
    Basic chart:

    Profile

    Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Immune System Pharmacy Medication Autoimmunity Specialty Drugs Autoimmune Disorders Immune Disorders

    Is CUE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 21 Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?
    Jun 4 Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting
    Jun 3 Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024
    May 30 Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
    May 11 Cue Biopharma First Quarter 2024 Earnings: Beats Expectations
    May 9 Cue Biopharma GAAP EPS of -$0.25 beats by $0.03, revenue of $1.7M beats by $0.49M
    May 9 Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
    May 8 Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
    Apr 24 Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    Apr 9 Q4 2023 Cue Biopharma Inc Earnings Call
    See more CUE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.89
    52 Week Low 0.9371
    Average Volume 390,027
    200-Day Moving Average 2.14
    50-Day Moving Average 1.60
    20-Day Moving Average 1.43
    10-Day Moving Average 1.33
    Average True Range 0.17
    RSI (14) 28.57
    ADX 13.75
    +DI 15.49
    -DI 31.54
    Chandelier Exit (Long, 3 ATRs) 1.27
    Chandelier Exit (Short, 3 ATRs) 1.46
    Upper Bollinger Bands 1.72
    Lower Bollinger Band 1.14
    Percent B (%b) -0.2
    BandWidth 40.73
    MACD Line -0.11
    MACD Signal Line -0.09
    MACD Histogram -0.0221
    Fundamentals Value
    Market Cap 46.03 Million
    Num Shares 45.1 Million
    EPS -1.20
    Price-to-Earnings (P/E) Ratio -0.85
    Price-to-Sales 27.76
    Price-to-Book 2.46
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.55
    Resistance 3 (R3) 1.58 1.44 1.46
    Resistance 2 (R2) 1.44 1.30 1.42 1.43
    Resistance 1 (R1) 1.23 1.22 1.16 1.20 1.40
    Pivot Point 1.08 1.08 1.05 1.07 1.08
    Support 1 (S1) 0.87 0.95 0.80 0.84 0.64
    Support 2 (S2) 0.73 0.86 0.71 0.61
    Support 3 (S3) 0.52 0.73 0.58
    Support 4 (S4) 0.49